Geneva Capital Management »

Vericel shares owned by Geneva Capital Management

Quarter-by-quarter ownership of Vericel (VCEL) shares owned by Geneva Capital Management from 13F filings

Historical chart of Geneva Capital Management investment in Vericel

Tip: Access up to 7 years of quarterly data

All positions including Vericel held by Geneva Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vericel by Geneva Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $47M 1.1M 42.25
2024-06-30 $31M 684k 45.88
2024-03-31 $35M 679k 52.02
2023-12-31 $17M 473k 35.61
2023-09-30 $15M 435k 33.52

More positions owned by Geneva Capital Management

Construction Partners Common-stock (ROAD)
Onto Innovation Common-stock (ONTO)
Kinsale Capital Group Common-stock (KNSL)
Exponent Common-stock (EXPO)
Aaon Common-stock (AAON)
ExlService Holdings Common-stock (EXLS)
RBC Bearings Common-stock (RBC)
Texas Roadhouse Common-stock (TXRH)
Descartes Systems Group Common-stock (DSGX)
Novanta Common-stock (NOVT)
Balchem Corp Common-stock (BCPC)
Tyler Technologies Common-stock (TYL)
Globus Med Common-stock (GMED)
ESCO Technologies Common-stock (ESE)
Trex Company Common-stock (TREX)

View all positions for Geneva Capital Management

Top funds holding Vericel

BlackRock
BlackRock
Brown Capital Management
Vanguard Group
State Street Corporation
Invesco
Conestoga Capital Advisors
Congress Asset Management
Jennifer Ranahan
Geode Capital Management
Geneva Capital Management
Bnp Paribas Investment Partners
Macquarie Group
Royal Bank of Canada
Federated Investors

View all funds holding Vericel